Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Transplantation | 89 | 2025 | 3310 | 7.420 |
Why?
|
Transplantation Tolerance | 33 | 2025 | 640 | 5.200 |
Why?
|
Graft Rejection | 80 | 2024 | 4499 | 4.380 |
Why?
|
Immune Tolerance | 35 | 2022 | 2324 | 2.740 |
Why?
|
Graft Survival | 59 | 2025 | 3890 | 2.480 |
Why?
|
Kidney Transplantation | 36 | 2025 | 4270 | 2.400 |
Why?
|
Transplantation, Homologous | 58 | 2024 | 4860 | 2.210 |
Why?
|
Swine, Miniature | 46 | 2018 | 971 | 1.960 |
Why?
|
Transplantation Immunology | 10 | 2019 | 541 | 1.930 |
Why?
|
Macaca fascicularis | 18 | 2025 | 907 | 1.910 |
Why?
|
Lung Transplantation | 23 | 2022 | 1311 | 1.900 |
Why?
|
Thymus Gland | 9 | 2024 | 1261 | 1.800 |
Why?
|
Major Histocompatibility Complex | 17 | 2017 | 879 | 1.610 |
Why?
|
Immunosuppressive Agents | 34 | 2024 | 4209 | 1.540 |
Why?
|
Swine | 57 | 2022 | 5988 | 1.350 |
Why?
|
Tissue Donors | 14 | 2025 | 2395 | 1.210 |
Why?
|
Lymphocyte Depletion | 10 | 2016 | 605 | 1.170 |
Why?
|
Organ Preservation | 8 | 2024 | 399 | 1.120 |
Why?
|
Organ Transplantation | 14 | 2024 | 1174 | 1.120 |
Why?
|
Killer Cells, Natural | 11 | 2014 | 2210 | 1.110 |
Why?
|
T-Lymphocytes, Regulatory | 18 | 2025 | 3111 | 1.010 |
Why?
|
Bone Marrow Transplantation | 9 | 2025 | 2729 | 0.970 |
Why?
|
Diphtheria Toxin | 9 | 2018 | 253 | 0.970 |
Why?
|
Isoantigens | 12 | 2020 | 562 | 0.920 |
Why?
|
Brain Death | 6 | 2024 | 360 | 0.920 |
Why?
|
Chimerism | 9 | 2020 | 154 | 0.880 |
Why?
|
Transplantation Chimera | 12 | 2021 | 609 | 0.880 |
Why?
|
Immunity, Innate | 12 | 2024 | 3081 | 0.840 |
Why?
|
Interleukin-2 | 9 | 2024 | 1896 | 0.830 |
Why?
|
Histocompatibility | 6 | 2021 | 327 | 0.760 |
Why?
|
Animals | 142 | 2025 | 168759 | 0.740 |
Why?
|
Cyclosporine | 10 | 2005 | 778 | 0.690 |
Why?
|
Heart | 10 | 2022 | 4414 | 0.680 |
Why?
|
Transplantation, Heterologous | 12 | 2022 | 2394 | 0.670 |
Why?
|
Histocompatibility Antigens Class I | 12 | 2009 | 1365 | 0.670 |
Why?
|
Immunotoxins | 6 | 2018 | 177 | 0.640 |
Why?
|
Transplantation | 1 | 2019 | 222 | 0.570 |
Why?
|
Coronary Vessels | 14 | 2021 | 3097 | 0.560 |
Why?
|
Kidney | 11 | 2024 | 7066 | 0.500 |
Why?
|
Perfusion | 5 | 2021 | 1407 | 0.490 |
Why?
|
Coronary Artery Disease | 9 | 2021 | 6546 | 0.480 |
Why?
|
Immunoconjugates | 5 | 2017 | 981 | 0.450 |
Why?
|
Coronary Disease | 9 | 2009 | 5912 | 0.440 |
Why?
|
Receptors, CCR4 | 4 | 2018 | 75 | 0.430 |
Why?
|
Models, Animal | 13 | 2019 | 2120 | 0.420 |
Why?
|
Interleukin-6 | 2 | 2022 | 3222 | 0.420 |
Why?
|
T-Lymphocytes | 19 | 2020 | 10261 | 0.410 |
Why?
|
Histocompatibility Antigens Class II | 8 | 2008 | 1441 | 0.410 |
Why?
|
Vascular Diseases | 5 | 2014 | 1159 | 0.400 |
Why?
|
Interleukin-15 | 2 | 2012 | 186 | 0.390 |
Why?
|
Interferon-gamma | 9 | 2024 | 3160 | 0.390 |
Why?
|
Skin Transplantation | 10 | 2015 | 1098 | 0.370 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 5 | 2021 | 305 | 0.370 |
Why?
|
Cryopreservation | 2 | 2018 | 728 | 0.370 |
Why?
|
Cardiac Myosins | 1 | 2011 | 128 | 0.360 |
Why?
|
Histocompatibility Testing | 8 | 2015 | 726 | 0.350 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2012 | 287 | 0.330 |
Why?
|
Transplantation Conditioning | 7 | 2017 | 1635 | 0.330 |
Why?
|
Antigens, Differentiation | 3 | 2001 | 919 | 0.330 |
Why?
|
Hematopoietic Stem Cell Mobilization | 2 | 2010 | 227 | 0.320 |
Why?
|
Ischemia | 1 | 2018 | 1909 | 0.320 |
Why?
|
Flow Cytometry | 16 | 2020 | 5881 | 0.310 |
Why?
|
Forkhead Transcription Factors | 6 | 2020 | 1624 | 0.310 |
Why?
|
Sirolimus | 4 | 2022 | 1545 | 0.300 |
Why?
|
Transplants | 2 | 2021 | 208 | 0.300 |
Why?
|
Histocompatibility Antigens | 3 | 2015 | 477 | 0.300 |
Why?
|
Isoantibodies | 8 | 2021 | 681 | 0.290 |
Why?
|
T-Lymphocytes, Cytotoxic | 5 | 2024 | 1801 | 0.290 |
Why?
|
Heart Valve Prosthesis | 6 | 2005 | 1466 | 0.270 |
Why?
|
Postoperative Complications | 14 | 2020 | 15747 | 0.270 |
Why?
|
Lymphocyte Culture Test, Mixed | 5 | 2015 | 511 | 0.260 |
Why?
|
Bioprosthesis | 3 | 2002 | 589 | 0.260 |
Why?
|
Primates | 3 | 2019 | 518 | 0.260 |
Why?
|
Mice, Inbred BALB C | 13 | 2022 | 6220 | 0.260 |
Why?
|
Erythropoietin | 2 | 2022 | 716 | 0.260 |
Why?
|
Organ Specificity | 4 | 2021 | 1965 | 0.260 |
Why?
|
Complement System Proteins | 4 | 2021 | 715 | 0.260 |
Why?
|
Heart Failure | 9 | 2024 | 11840 | 0.250 |
Why?
|
Coronary Artery Bypass | 7 | 2005 | 2186 | 0.250 |
Why?
|
Immunity, Cellular | 5 | 2011 | 1555 | 0.250 |
Why?
|
Tissue and Organ Procurement | 5 | 2024 | 989 | 0.250 |
Why?
|
Adaptive Immunity | 4 | 2021 | 734 | 0.250 |
Why?
|
Myocardium | 8 | 2016 | 4760 | 0.250 |
Why?
|
Antibodies, Monoclonal | 13 | 2016 | 9249 | 0.240 |
Why?
|
CD40 Ligand | 3 | 2022 | 528 | 0.230 |
Why?
|
Chemokines, CXC | 1 | 2006 | 416 | 0.230 |
Why?
|
Abscess | 1 | 2008 | 606 | 0.230 |
Why?
|
Macrophages | 5 | 2022 | 5772 | 0.220 |
Why?
|
Mice | 41 | 2024 | 81818 | 0.220 |
Why?
|
Humans | 103 | 2024 | 765956 | 0.220 |
Why?
|
Mycophenolic Acid | 1 | 2005 | 346 | 0.210 |
Why?
|
Mice, Inbred C57BL | 22 | 2023 | 22331 | 0.210 |
Why?
|
Endothelin-1 | 2 | 2015 | 295 | 0.210 |
Why?
|
Hypersensitivity, Delayed | 4 | 2011 | 490 | 0.210 |
Why?
|
Mice, Inbred DBA | 6 | 2023 | 623 | 0.210 |
Why?
|
Stem Cell Transplantation | 3 | 2013 | 1602 | 0.210 |
Why?
|
Cytotoxicity, Immunologic | 4 | 2015 | 1347 | 0.210 |
Why?
|
Endothelium, Vascular | 4 | 2007 | 4427 | 0.200 |
Why?
|
Immunologic Memory | 5 | 2019 | 1375 | 0.200 |
Why?
|
CD8-Positive T-Lymphocytes | 6 | 2024 | 4642 | 0.200 |
Why?
|
Autoantibodies | 1 | 2011 | 2113 | 0.200 |
Why?
|
Drug Costs | 1 | 2010 | 1193 | 0.200 |
Why?
|
Coronary Stenosis | 1 | 2008 | 800 | 0.200 |
Why?
|
Aortic Diseases | 1 | 2008 | 729 | 0.190 |
Why?
|
Cytokines | 3 | 2022 | 7421 | 0.190 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 3 | 1989 | 894 | 0.190 |
Why?
|
Tunica Intima | 4 | 2007 | 455 | 0.190 |
Why?
|
Recombinant Fusion Proteins | 6 | 2018 | 3737 | 0.180 |
Why?
|
Radiation Tolerance | 1 | 2003 | 475 | 0.180 |
Why?
|
Proteus Infections | 1 | 2000 | 10 | 0.180 |
Why?
|
Proteus vulgaris | 1 | 2000 | 8 | 0.180 |
Why?
|
Aortic Valve | 6 | 2005 | 1968 | 0.180 |
Why?
|
Heart Diseases | 3 | 2020 | 2821 | 0.180 |
Why?
|
Thymectomy | 4 | 2006 | 200 | 0.180 |
Why?
|
Mediastinitis | 1 | 2000 | 49 | 0.180 |
Why?
|
Stromal Cells | 1 | 2006 | 1329 | 0.170 |
Why?
|
Coronary Circulation | 2 | 2005 | 1602 | 0.170 |
Why?
|
Receptors, Erythropoietin | 2 | 2019 | 145 | 0.170 |
Why?
|
Graft Enhancement, Immunologic | 1 | 2000 | 58 | 0.170 |
Why?
|
Blood Transfusion | 3 | 2005 | 1297 | 0.170 |
Why?
|
Glomerular Filtration Rate | 3 | 2024 | 2233 | 0.170 |
Why?
|
Antigens, Heterophile | 1 | 2000 | 70 | 0.170 |
Why?
|
Time Factors | 22 | 2024 | 40065 | 0.160 |
Why?
|
Multiple Organ Failure | 1 | 2002 | 390 | 0.160 |
Why?
|
Antibodies, Blocking | 1 | 2000 | 249 | 0.160 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2021 | 616 | 0.160 |
Why?
|
Acute Disease | 7 | 2011 | 7232 | 0.160 |
Why?
|
Myocardial Ischemia | 3 | 2006 | 2128 | 0.160 |
Why?
|
Immunization | 5 | 2011 | 1219 | 0.160 |
Why?
|
Blood Vessels | 1 | 2005 | 1113 | 0.160 |
Why?
|
Neovascularization, Physiologic | 1 | 2006 | 1375 | 0.160 |
Why?
|
Medication Adherence | 1 | 2010 | 2190 | 0.150 |
Why?
|
Adenosine Triphosphate | 2 | 2015 | 1999 | 0.150 |
Why?
|
Hematopoiesis | 2 | 2015 | 2058 | 0.150 |
Why?
|
Immune System | 2 | 2021 | 799 | 0.150 |
Why?
|
Ventricular Septal Rupture | 1 | 1998 | 17 | 0.150 |
Why?
|
Macaca mulatta | 1 | 2024 | 2341 | 0.150 |
Why?
|
Blood Vessel Prosthesis | 2 | 2000 | 912 | 0.150 |
Why?
|
Organ Preservation Solutions | 2 | 2018 | 105 | 0.150 |
Why?
|
Genes, MHC Class I | 2 | 1989 | 236 | 0.150 |
Why?
|
Nephritis, Interstitial | 1 | 2019 | 158 | 0.140 |
Why?
|
Donor Selection | 1 | 2020 | 242 | 0.140 |
Why?
|
Maternal-Fetal Exchange | 1 | 2020 | 453 | 0.140 |
Why?
|
Complement C4b | 2 | 2010 | 124 | 0.140 |
Why?
|
Immunoglobulin M | 3 | 2016 | 1528 | 0.140 |
Why?
|
Primary Graft Dysfunction | 1 | 2018 | 112 | 0.140 |
Why?
|
Male | 48 | 2025 | 363691 | 0.140 |
Why?
|
Diabetes Mellitus | 1 | 2015 | 5891 | 0.140 |
Why?
|
Transplantation, Heterotopic | 2 | 1996 | 175 | 0.130 |
Why?
|
Photoreceptor Cells | 4 | 1984 | 234 | 0.130 |
Why?
|
Receptor Cross-Talk | 1 | 2017 | 118 | 0.130 |
Why?
|
Kidney Diseases | 2 | 2020 | 2098 | 0.130 |
Why?
|
Antigen-Presenting Cells | 1 | 2020 | 962 | 0.130 |
Why?
|
Immediate-Early Proteins | 1 | 2019 | 444 | 0.130 |
Why?
|
Tacrolimus | 4 | 2015 | 753 | 0.130 |
Why?
|
Heart Valve Prosthesis Implantation | 3 | 2005 | 1566 | 0.130 |
Why?
|
Mice, Inbred C3H | 8 | 2020 | 914 | 0.130 |
Why?
|
Lymphocytes | 2 | 2003 | 2599 | 0.130 |
Why?
|
Glycosuria | 1 | 2015 | 44 | 0.130 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 5 | 2019 | 3807 | 0.130 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2019 | 791 | 0.120 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2015 | 318 | 0.120 |
Why?
|
Ketosis | 1 | 2015 | 46 | 0.120 |
Why?
|
Lupus Nephritis | 1 | 2019 | 320 | 0.120 |
Why?
|
Mitral Valve | 3 | 2005 | 1476 | 0.120 |
Why?
|
Prosthesis-Related Infections | 1 | 2000 | 496 | 0.120 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2017 | 196 | 0.120 |
Why?
|
HLA Antigens | 4 | 2021 | 1339 | 0.120 |
Why?
|
Reperfusion Injury | 1 | 2021 | 1042 | 0.120 |
Why?
|
Hemodynamics | 2 | 2022 | 4183 | 0.120 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2016 | 340 | 0.110 |
Why?
|
Amyloidosis | 2 | 2013 | 885 | 0.110 |
Why?
|
Antigen Presentation | 1 | 2020 | 1250 | 0.110 |
Why?
|
Mannitol | 1 | 2014 | 176 | 0.110 |
Why?
|
Neointima | 1 | 2014 | 133 | 0.110 |
Why?
|
Antigens, CD19 | 1 | 2017 | 443 | 0.110 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2000 | 700 | 0.110 |
Why?
|
Disaccharides | 1 | 2014 | 170 | 0.110 |
Why?
|
Peptides | 2 | 2007 | 4331 | 0.110 |
Why?
|
Histidine | 1 | 2014 | 301 | 0.110 |
Why?
|
Lung Diseases | 3 | 2015 | 1940 | 0.110 |
Why?
|
Electrolytes | 1 | 2014 | 280 | 0.110 |
Why?
|
CD4-Positive T-Lymphocytes | 5 | 2012 | 4405 | 0.110 |
Why?
|
Interleukin-10 | 4 | 2012 | 1183 | 0.110 |
Why?
|
Pulsatile Flow | 1 | 2014 | 318 | 0.110 |
Why?
|
T-Lymphocyte Subsets | 2 | 2001 | 1811 | 0.110 |
Why?
|
Chimera | 1 | 2014 | 455 | 0.110 |
Why?
|
Glutamates | 1 | 2014 | 384 | 0.100 |
Why?
|
Disease Models, Animal | 9 | 2020 | 18294 | 0.100 |
Why?
|
Sus scrofa | 1 | 2014 | 430 | 0.100 |
Why?
|
B-Lymphocytes | 4 | 2019 | 4778 | 0.100 |
Why?
|
Th17 Cells | 1 | 2019 | 786 | 0.100 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2014 | 684 | 0.100 |
Why?
|
Kidney Function Tests | 3 | 2024 | 683 | 0.100 |
Why?
|
Apoptosis | 4 | 2015 | 9514 | 0.100 |
Why?
|
Ventricular Function, Left | 2 | 2016 | 3928 | 0.100 |
Why?
|
Acute Kidney Injury | 1 | 2024 | 1946 | 0.100 |
Why?
|
Liver Transplantation | 2 | 2014 | 2412 | 0.100 |
Why?
|
Glutathione | 1 | 2014 | 588 | 0.100 |
Why?
|
Lymphocyte Activation | 4 | 2012 | 5501 | 0.090 |
Why?
|
Pichia | 3 | 2017 | 47 | 0.090 |
Why?
|
Bioartificial Organs | 1 | 2011 | 46 | 0.090 |
Why?
|
Chronic Disease | 10 | 2011 | 9347 | 0.090 |
Why?
|
Receptors, Natural Killer Cell | 1 | 2011 | 55 | 0.090 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2012 | 304 | 0.090 |
Why?
|
Epoetin Alfa | 2 | 2022 | 78 | 0.090 |
Why?
|
Gastroesophageal Reflux | 2 | 2008 | 833 | 0.090 |
Why?
|
Aortic Valve Insufficiency | 3 | 2005 | 575 | 0.090 |
Why?
|
Rats, Inbred Lew | 2 | 2006 | 1167 | 0.090 |
Why?
|
Cold Temperature | 1 | 2014 | 794 | 0.090 |
Why?
|
Transfection | 2 | 1989 | 5743 | 0.090 |
Why?
|
Dendritic Cells | 2 | 2020 | 2747 | 0.090 |
Why?
|
Endarteritis | 1 | 2010 | 5 | 0.090 |
Why?
|
Lung | 6 | 2019 | 10033 | 0.090 |
Why?
|
Aorta | 3 | 2008 | 2028 | 0.090 |
Why?
|
Animals, Inbred Strains | 3 | 2003 | 13 | 0.080 |
Why?
|
Treatment Outcome | 13 | 2024 | 65189 | 0.080 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2011 | 303 | 0.080 |
Why?
|
Embolism, Cholesterol | 1 | 2009 | 33 | 0.080 |
Why?
|
Arenaviridae Infections | 1 | 2009 | 53 | 0.080 |
Why?
|
Stem Cell Factor | 1 | 2010 | 194 | 0.080 |
Why?
|
Hepatitis C | 1 | 2020 | 1597 | 0.080 |
Why?
|
Cardiopulmonary Bypass | 2 | 2009 | 1090 | 0.080 |
Why?
|
Nanoparticles | 1 | 2021 | 1964 | 0.080 |
Why?
|
Membrane Glycoproteins | 1 | 2000 | 3690 | 0.080 |
Why?
|
Peptide Fragments | 3 | 2010 | 5125 | 0.080 |
Why?
|
Cell Proliferation | 6 | 2015 | 10429 | 0.080 |
Why?
|
Melphalan | 1 | 2010 | 425 | 0.080 |
Why?
|
Amino Acid Sequence | 5 | 2015 | 13400 | 0.080 |
Why?
|
Lymphocytic choriomeningitis virus | 1 | 2009 | 175 | 0.080 |
Why?
|
Diabetes Complications | 1 | 2015 | 1316 | 0.080 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2010 | 414 | 0.080 |
Why?
|
Tracheostomy | 1 | 1992 | 429 | 0.080 |
Why?
|
Kidney Failure, Chronic | 2 | 2024 | 2495 | 0.080 |
Why?
|
Cardiac Surgical Procedures | 4 | 2009 | 3675 | 0.070 |
Why?
|
Genes, MHC Class II | 1 | 1989 | 433 | 0.070 |
Why?
|
Insurance, Pharmaceutical Services | 1 | 2010 | 347 | 0.070 |
Why?
|
Reoperation | 7 | 2009 | 4294 | 0.070 |
Why?
|
Leukapheresis | 2 | 2010 | 150 | 0.070 |
Why?
|
Carrageenan | 1 | 2007 | 65 | 0.070 |
Why?
|
Rats | 7 | 2011 | 23707 | 0.070 |
Why?
|
Infusions, Intra-Arterial | 1 | 2008 | 218 | 0.070 |
Why?
|
Molecular Sequence Data | 5 | 2015 | 17594 | 0.070 |
Why?
|
Cells, Cultured | 6 | 2019 | 18973 | 0.070 |
Why?
|
H-2 Antigens | 1 | 1988 | 359 | 0.070 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2010 | 633 | 0.070 |
Why?
|
Leukocytes | 1 | 2015 | 2027 | 0.070 |
Why?
|
Toll-Like Receptors | 1 | 2010 | 583 | 0.070 |
Why?
|
Vision, Ocular | 3 | 1979 | 457 | 0.070 |
Why?
|
Immunotherapy | 2 | 2021 | 4752 | 0.070 |
Why?
|
Immunoglobulin G | 4 | 2006 | 4528 | 0.070 |
Why?
|
Form Perception | 3 | 1984 | 175 | 0.070 |
Why?
|
Antigens, Ly | 1 | 1987 | 296 | 0.070 |
Why?
|
Complement C4 | 1 | 2007 | 208 | 0.070 |
Why?
|
Arteries | 2 | 2010 | 1118 | 0.060 |
Why?
|
Aortic Aneurysm | 2 | 2009 | 623 | 0.060 |
Why?
|
Antigens, CD | 3 | 2001 | 4025 | 0.060 |
Why?
|
Mitral Valve Insufficiency | 2 | 2005 | 1414 | 0.060 |
Why?
|
Myocytes, Cardiac | 1 | 2014 | 1668 | 0.060 |
Why?
|
Debridement | 1 | 2008 | 495 | 0.060 |
Why?
|
Heart Valve Diseases | 2 | 2004 | 1030 | 0.060 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6309 | 0.060 |
Why?
|
Endothelium | 1 | 2008 | 767 | 0.060 |
Why?
|
Oxygen Consumption | 1 | 2011 | 1870 | 0.060 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2016 | 2136 | 0.060 |
Why?
|
Self Tolerance | 1 | 2005 | 119 | 0.060 |
Why?
|
Stem Cells | 2 | 2015 | 3540 | 0.060 |
Why?
|
Biopsy | 3 | 2012 | 6763 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2021 | 7851 | 0.060 |
Why?
|
Immunocompromised Host | 1 | 2009 | 866 | 0.060 |
Why?
|
Adult | 17 | 2024 | 223038 | 0.060 |
Why?
|
Chemokine CXCL12 | 1 | 2006 | 455 | 0.060 |
Why?
|
Bronchiolitis Obliterans | 2 | 2008 | 221 | 0.060 |
Why?
|
Female | 26 | 2024 | 396101 | 0.060 |
Why?
|
Adaptation, Physiological | 3 | 2007 | 1308 | 0.060 |
Why?
|
Adaptation, Ocular | 1 | 1984 | 89 | 0.050 |
Why?
|
Adoptive Transfer | 2 | 2020 | 827 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2015 | 5753 | 0.050 |
Why?
|
Color Perception | 3 | 1980 | 212 | 0.050 |
Why?
|
Follow-Up Studies | 8 | 2024 | 39194 | 0.050 |
Why?
|
Middle Aged | 17 | 2024 | 223004 | 0.050 |
Why?
|
Intra-Aortic Balloon Pumping | 2 | 2002 | 220 | 0.050 |
Why?
|
Forecasting | 3 | 2004 | 2936 | 0.050 |
Why?
|
Leukocytes, Mononuclear | 2 | 2024 | 1857 | 0.050 |
Why?
|
Cell Communication | 2 | 2020 | 1660 | 0.050 |
Why?
|
Galactosyltransferases | 1 | 2005 | 284 | 0.050 |
Why?
|
Heart-Assist Devices | 1 | 2014 | 1296 | 0.050 |
Why?
|
Prognosis | 4 | 2024 | 29921 | 0.050 |
Why?
|
Survival Rate | 5 | 2020 | 12795 | 0.050 |
Why?
|
Coculture Techniques | 2 | 2011 | 1336 | 0.050 |
Why?
|
Terminology as Topic | 1 | 2010 | 1534 | 0.050 |
Why?
|
Recombinant Proteins | 2 | 2014 | 6493 | 0.050 |
Why?
|
Homozygote | 2 | 2006 | 1775 | 0.050 |
Why?
|
Oxygen | 1 | 2014 | 4241 | 0.050 |
Why?
|
Mice, Inbred NOD | 2 | 2017 | 1837 | 0.050 |
Why?
|
Hypoglycemic Agents | 1 | 2015 | 3110 | 0.050 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2006 | 891 | 0.050 |
Why?
|
Gadolinium | 1 | 2007 | 965 | 0.050 |
Why?
|
Risk Factors | 10 | 2024 | 74836 | 0.050 |
Why?
|
Renal Replacement Therapy | 1 | 2024 | 281 | 0.050 |
Why?
|
Gene Expression Regulation | 3 | 2021 | 11888 | 0.050 |
Why?
|
Guinea Pigs | 1 | 2004 | 1300 | 0.050 |
Why?
|
Molecular Probes | 1 | 2004 | 307 | 0.050 |
Why?
|
Papio | 1 | 2004 | 671 | 0.050 |
Why?
|
Pulmonary Artery | 2 | 2022 | 1935 | 0.050 |
Why?
|
Antineoplastic Agents | 2 | 2017 | 13648 | 0.050 |
Why?
|
Immunohistochemistry | 4 | 2017 | 11022 | 0.050 |
Why?
|
Mice, SCID | 2 | 2017 | 2630 | 0.050 |
Why?
|
Endothelial Cells | 2 | 2021 | 3584 | 0.050 |
Why?
|
Surgical Wound Infection | 2 | 2002 | 1543 | 0.050 |
Why?
|
Echocardiography | 3 | 2016 | 5045 | 0.050 |
Why?
|
Phagocytosis | 1 | 2007 | 1520 | 0.050 |
Why?
|
Antibodies | 1 | 2010 | 2417 | 0.050 |
Why?
|
Mice, Knockout | 4 | 2024 | 14447 | 0.050 |
Why?
|
Retrospective Studies | 10 | 2024 | 81515 | 0.050 |
Why?
|
Pattern Recognition, Visual | 2 | 1984 | 820 | 0.050 |
Why?
|
Cardiomyopathies | 1 | 2013 | 2067 | 0.050 |
Why?
|
Whole-Body Irradiation | 2 | 2014 | 438 | 0.050 |
Why?
|
Pulmonary Circulation | 1 | 2004 | 741 | 0.050 |
Why?
|
Insulin | 1 | 2015 | 6599 | 0.040 |
Why?
|
Body Constitution | 1 | 2001 | 272 | 0.040 |
Why?
|
Blood Glucose | 1 | 2015 | 6425 | 0.040 |
Why?
|
Respiratory Mucosa | 1 | 2004 | 438 | 0.040 |
Why?
|
STAT5 Transcription Factor | 1 | 2021 | 269 | 0.040 |
Why?
|
Interphase | 1 | 2001 | 226 | 0.040 |
Why?
|
Povidone-Iodine | 1 | 2000 | 54 | 0.040 |
Why?
|
Antilymphocyte Serum | 2 | 2015 | 493 | 0.040 |
Why?
|
Leukocyte Transfusion | 1 | 2000 | 58 | 0.040 |
Why?
|
Endarterectomy, Carotid | 1 | 2005 | 557 | 0.040 |
Why?
|
Cricetinae | 1 | 2004 | 2411 | 0.040 |
Why?
|
Protein Kinases | 1 | 2007 | 1611 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2010 | 3715 | 0.040 |
Why?
|
Endocarditis | 2 | 2001 | 350 | 0.040 |
Why?
|
Aristolochic Acids | 1 | 2019 | 13 | 0.040 |
Why?
|
Fibrosis | 1 | 2007 | 2070 | 0.040 |
Why?
|
Clonal Anergy | 1 | 2000 | 169 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2017 | 10729 | 0.040 |
Why?
|
Base Sequence | 3 | 2015 | 12403 | 0.040 |
Why?
|
Breeding | 1 | 1999 | 49 | 0.040 |
Why?
|
Therapeutic Irrigation | 1 | 2000 | 297 | 0.040 |
Why?
|
Mice, Inbred MRL lpr | 1 | 2019 | 159 | 0.040 |
Why?
|
Pennsylvania | 1 | 2020 | 614 | 0.040 |
Why?
|
Tissue and Organ Harvesting | 1 | 2002 | 373 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2002 | 8529 | 0.040 |
Why?
|
Death | 1 | 2023 | 686 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2019 | 124 | 0.040 |
Why?
|
Myocardial Infarction | 2 | 2016 | 11501 | 0.040 |
Why?
|
Antibodies, Heterophile | 1 | 1998 | 128 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2007 | 2453 | 0.040 |
Why?
|
Liver | 1 | 2014 | 7562 | 0.040 |
Why?
|
Autoimmunity | 2 | 2008 | 1354 | 0.040 |
Why?
|
Aged | 14 | 2024 | 171114 | 0.040 |
Why?
|
Head and Neck Neoplasms | 1 | 1992 | 2921 | 0.040 |
Why?
|
Models, Biological | 3 | 2007 | 9443 | 0.040 |
Why?
|
Vimentin | 1 | 2019 | 258 | 0.040 |
Why?
|
Evidence-Based Medicine | 2 | 2014 | 3685 | 0.040 |
Why?
|
Species Specificity | 2 | 2004 | 2406 | 0.040 |
Why?
|
Receptors, Interleukin | 1 | 2019 | 243 | 0.040 |
Why?
|
Antibody Specificity | 2 | 1997 | 1061 | 0.040 |
Why?
|
Phosphorylation | 3 | 2019 | 8278 | 0.040 |
Why?
|
Pregnancy | 1 | 2020 | 30258 | 0.040 |
Why?
|
Prosthesis Failure | 2 | 2005 | 1191 | 0.040 |
Why?
|
Transplantation, Autologous | 2 | 2015 | 2120 | 0.040 |
Why?
|
Mice, Transgenic | 3 | 2019 | 9550 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2017 | 5849 | 0.040 |
Why?
|
Veins | 1 | 2002 | 764 | 0.040 |
Why?
|
Haplotypes | 1 | 2004 | 2728 | 0.040 |
Why?
|
Hormones | 1 | 2021 | 863 | 0.040 |
Why?
|
Pulmonary Ventilation | 1 | 2019 | 377 | 0.030 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2021 | 702 | 0.030 |
Why?
|
Safety-Based Drug Withdrawals | 1 | 2017 | 36 | 0.030 |
Why?
|
Graft vs Host Disease | 2 | 2012 | 3078 | 0.030 |
Why?
|
Myosins | 1 | 2019 | 408 | 0.030 |
Why?
|
Myeloid Cells | 1 | 2022 | 839 | 0.030 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2001 | 825 | 0.030 |
Why?
|
Heart Valves | 1 | 1999 | 284 | 0.030 |
Why?
|
Equipment Design | 2 | 2019 | 3481 | 0.030 |
Why?
|
Regression Analysis | 2 | 2013 | 6321 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2021 | 2266 | 0.030 |
Why?
|
Actuarial Analysis | 3 | 2005 | 366 | 0.030 |
Why?
|
Prospective Studies | 5 | 2024 | 54806 | 0.030 |
Why?
|
Child | 3 | 2015 | 80563 | 0.030 |
Why?
|
Inflammation | 3 | 2022 | 10850 | 0.030 |
Why?
|
Survival Analysis | 4 | 2018 | 10070 | 0.030 |
Why?
|
Heart Neoplasms | 1 | 1999 | 375 | 0.030 |
Why?
|
Protein Binding | 3 | 2014 | 9296 | 0.030 |
Why?
|
Body Mass Index | 1 | 2013 | 13039 | 0.030 |
Why?
|
Recurrence | 1 | 2008 | 8501 | 0.030 |
Why?
|
Renal Insufficiency | 2 | 1998 | 804 | 0.030 |
Why?
|
Age Factors | 3 | 2014 | 18380 | 0.030 |
Why?
|
Leiomyosarcoma | 1 | 1999 | 423 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 1997 | 790 | 0.030 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2021 | 1499 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1789 | 0.030 |
Why?
|
Cross Reactions | 1 | 2016 | 824 | 0.030 |
Why?
|
Mice, Inbred Strains | 2 | 2007 | 1770 | 0.030 |
Why?
|
United States | 2 | 2020 | 72898 | 0.030 |
Why?
|
Visual Pathways | 1 | 1979 | 555 | 0.030 |
Why?
|
Horses | 1 | 2015 | 293 | 0.030 |
Why?
|
Cell Separation | 1 | 2020 | 1718 | 0.030 |
Why?
|
Cardiac Tamponade | 1 | 1995 | 176 | 0.030 |
Why?
|
Cell Survival | 2 | 2017 | 5746 | 0.030 |
Why?
|
Myosin Heavy Chains | 1 | 2016 | 403 | 0.030 |
Why?
|
Plasma Cells | 1 | 2017 | 591 | 0.030 |
Why?
|
Gene Expression Profiling | 2 | 2021 | 9524 | 0.030 |
Why?
|
Endocarditis, Bacterial | 1 | 1998 | 434 | 0.030 |
Why?
|
Phenotype | 1 | 2012 | 16721 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 2015 | 682 | 0.030 |
Why?
|
Organ Size | 1 | 1999 | 2261 | 0.030 |
Why?
|
Receptors, Interleukin-6 | 1 | 2015 | 226 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2021 | 2140 | 0.030 |
Why?
|
Sensory Thresholds | 4 | 1984 | 377 | 0.030 |
Why?
|
Aged, 80 and over | 5 | 1998 | 59488 | 0.030 |
Why?
|
Incidence | 2 | 2024 | 21480 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2019 | 3513 | 0.030 |
Why?
|
Monocytes | 1 | 2022 | 2595 | 0.030 |
Why?
|
Anastomosis, Surgical | 2 | 1996 | 990 | 0.030 |
Why?
|
Suture Techniques | 1 | 1998 | 773 | 0.030 |
Why?
|
Interleukin-17 | 1 | 2019 | 921 | 0.030 |
Why?
|
Thoracic Injuries | 1 | 1995 | 288 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2004 | 5302 | 0.030 |
Why?
|
Binding, Competitive | 1 | 2014 | 1140 | 0.020 |
Why?
|
DNA | 2 | 2017 | 7202 | 0.020 |
Why?
|
Cell Line | 2 | 2014 | 15543 | 0.020 |
Why?
|
Rats, Nude | 1 | 2011 | 105 | 0.020 |
Why?
|
Surgical Flaps | 1 | 2000 | 1677 | 0.020 |
Why?
|
Radiation Chimera | 1 | 2011 | 216 | 0.020 |
Why?
|
H-Y Antigen | 1 | 2011 | 42 | 0.020 |
Why?
|
Mice, Congenic | 1 | 2011 | 98 | 0.020 |
Why?
|
Lung Compliance | 1 | 2011 | 207 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2022 | 3454 | 0.020 |
Why?
|
Tumor Burden | 1 | 2017 | 1885 | 0.020 |
Why?
|
Prostheses and Implants | 1 | 1998 | 1273 | 0.020 |
Why?
|
Registries | 2 | 2020 | 8297 | 0.020 |
Why?
|
Ribs | 1 | 1992 | 254 | 0.020 |
Why?
|
Troponin T | 1 | 2016 | 785 | 0.020 |
Why?
|
Disease Management | 1 | 2021 | 2535 | 0.020 |
Why?
|
Cause of Death | 2 | 1998 | 3708 | 0.020 |
Why?
|
Blood Group Incompatibility | 1 | 2011 | 134 | 0.020 |
Why?
|
Blood Gas Analysis | 1 | 2011 | 380 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2021 | 3141 | 0.020 |
Why?
|
Clavicle | 1 | 1992 | 224 | 0.020 |
Why?
|
Patient Selection | 1 | 2022 | 4255 | 0.020 |
Why?
|
Aortic Valve Stenosis | 1 | 2002 | 2023 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2017 | 17075 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2017 | 6113 | 0.020 |
Why?
|
Organ Culture Techniques | 1 | 2011 | 788 | 0.020 |
Why?
|
Aspartate Aminotransferases | 1 | 2010 | 415 | 0.020 |
Why?
|
Wounds, Nonpenetrating | 1 | 1995 | 807 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2017 | 3608 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2014 | 959 | 0.020 |
Why?
|
bcl-X Protein | 1 | 2010 | 414 | 0.020 |
Why?
|
Waiting Lists | 1 | 2013 | 777 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2019 | 2631 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2014 | 1441 | 0.020 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2010 | 266 | 0.020 |
Why?
|
Splenectomy | 1 | 2010 | 390 | 0.020 |
Why?
|
Mice, Inbred CBA | 1 | 1989 | 439 | 0.020 |
Why?
|
Rheology | 1 | 2009 | 348 | 0.020 |
Why?
|
Interleukin-1 | 1 | 2012 | 1243 | 0.020 |
Why?
|
Mitochondria | 1 | 2021 | 3673 | 0.020 |
Why?
|
Neoplasms | 1 | 2017 | 22340 | 0.020 |
Why?
|
Alanine | 1 | 2010 | 612 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 1998 | 12057 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2000 | 3401 | 0.020 |
Why?
|
Ultrasonography, Interventional | 1 | 1996 | 1531 | 0.020 |
Why?
|
Skin | 1 | 2001 | 4489 | 0.020 |
Why?
|
Cardiotonic Agents | 1 | 2010 | 538 | 0.020 |
Why?
|
Length of Stay | 2 | 1998 | 6485 | 0.020 |
Why?
|
Signal Transduction | 3 | 2021 | 23600 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2020 | 3050 | 0.020 |
Why?
|
Hypertension, Pulmonary | 1 | 1998 | 1604 | 0.020 |
Why?
|
Risk | 1 | 2019 | 9591 | 0.020 |
Why?
|
Immunization, Passive | 1 | 1989 | 616 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2009 | 1745 | 0.020 |
Why?
|
Blotting, Western | 1 | 2014 | 5020 | 0.020 |
Why?
|
ABO Blood-Group System | 1 | 2009 | 380 | 0.020 |
Why?
|
Gastrostomy | 1 | 2008 | 327 | 0.020 |
Why?
|
Disease Progression | 2 | 2016 | 13631 | 0.020 |
Why?
|
Cell Transplantation | 1 | 2008 | 473 | 0.020 |
Why?
|
Materials Testing | 1 | 2009 | 868 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2023 | 11640 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2009 | 1381 | 0.020 |
Why?
|
Muromonab-CD3 | 1 | 2005 | 104 | 0.020 |
Why?
|
Islets of Langerhans Transplantation | 1 | 2010 | 746 | 0.020 |
Why?
|
beta Catenin | 1 | 2010 | 1043 | 0.020 |
Why?
|
History, Ancient | 1 | 2005 | 213 | 0.010 |
Why?
|
Spleen | 1 | 2011 | 2296 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4562 | 0.010 |
Why?
|
Rats, Inbred WF | 1 | 2004 | 139 | 0.010 |
Why?
|
Sex Factors | 1 | 1998 | 10602 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12509 | 0.010 |
Why?
|
Perceptual Masking | 1 | 1984 | 90 | 0.010 |
Why?
|
Islets of Langerhans | 1 | 2010 | 1349 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2011 | 1657 | 0.010 |
Why?
|
International Cooperation | 1 | 2010 | 1432 | 0.010 |
Why?
|
Spectrophotometry | 1 | 1984 | 288 | 0.010 |
Why?
|
Biomedical Research | 1 | 2019 | 3458 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6499 | 0.010 |
Why?
|
Coloring Agents | 1 | 2005 | 564 | 0.010 |
Why?
|
Discrimination Learning | 1 | 1984 | 276 | 0.010 |
Why?
|
Risk Assessment | 1 | 2004 | 24283 | 0.010 |
Why?
|
Esophageal Neoplasms | 1 | 1992 | 1661 | 0.010 |
Why?
|
Capillaries | 1 | 2005 | 755 | 0.010 |
Why?
|
Minor Histocompatibility Loci | 1 | 2001 | 16 | 0.010 |
Why?
|
Hospitalization | 2 | 1998 | 10808 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 2002 | 2077 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15880 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2005 | 2476 | 0.010 |
Why?
|
Models, Genetic | 1 | 2011 | 3448 | 0.010 |
Why?
|
Motion Perception | 1 | 1984 | 377 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2012 | 4348 | 0.010 |
Why?
|
Surgical Wound Dehiscence | 1 | 2002 | 215 | 0.010 |
Why?
|
Hospital Mortality | 3 | 2001 | 5343 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2011 | 8102 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2009 | 2428 | 0.010 |
Why?
|
Nephrectomy | 1 | 2005 | 927 | 0.010 |
Why?
|
Respiratory Function Tests | 1 | 2005 | 1693 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2004 | 3051 | 0.010 |
Why?
|
Hypersensitivity | 1 | 2007 | 1168 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 2010 | 2226 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2007 | 2056 | 0.010 |
Why?
|
Societies, Medical | 1 | 2010 | 3956 | 0.010 |
Why?
|
Gene Deletion | 1 | 2005 | 2666 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2013 | 15398 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2012 | 12769 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2007 | 4247 | 0.010 |
Why?
|
Stroke Volume | 1 | 2010 | 5596 | 0.010 |
Why?
|
Methods | 1 | 1996 | 1052 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1999 | 2548 | 0.010 |
Why?
|
Brain | 1 | 2022 | 27178 | 0.010 |
Why?
|
Fatal Outcome | 1 | 1999 | 1831 | 0.010 |
Why?
|
Motion | 1 | 1978 | 781 | 0.010 |
Why?
|
Multiple Trauma | 1 | 1995 | 369 | 0.010 |
Why?
|
Photic Stimulation | 1 | 1979 | 1993 | 0.010 |
Why?
|
Genotype | 1 | 2006 | 13024 | 0.010 |
Why?
|
Action Potentials | 1 | 1978 | 1838 | 0.010 |
Why?
|
Carotid Artery Diseases | 1 | 1997 | 874 | 0.010 |
Why?
|
Young Adult | 1 | 2017 | 59886 | 0.010 |
Why?
|
Cerebrovascular Disorders | 1 | 1997 | 1470 | 0.010 |
Why?
|
Accidents, Traffic | 1 | 1995 | 818 | 0.010 |
Why?
|
Attitude to Health | 1 | 1997 | 2020 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 2 | 2009 | 36532 | 0.000 |
Why?
|
Epitopes | 1 | 1992 | 2523 | 0.000 |
Why?
|
Patient Satisfaction | 1 | 1997 | 3475 | 0.000 |
Why?
|
Boston | 1 | 1997 | 9338 | 0.000 |
Why?
|
Referral and Consultation | 1 | 1997 | 3615 | 0.000 |
Why?
|
Psychophysics | 1 | 1984 | 294 | 0.000 |
Why?
|
Stroke | 1 | 2004 | 9747 | 0.000 |
Why?
|
Visual Perception | 1 | 1980 | 1394 | 0.000 |
Why?
|